Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Acarix AB

Market Cap 304M 32.21M 27.82M 25.65M 24.05M 45.04M 3.06B 45.69M 118M 1.49B 121M 118M 5.2B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 304M 32.21M 27.82M 25.65M 24.05M 45.04M 3.06B 45.69M 118M 1.49B 121M 118M 5.2B EV / Sales 2026 *
15.9x
EV / Sales 2027 * 4.37x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-3.03%
1 week-0.78%
Current month+0.79%
1 month-1.92%
3 months-7.91%
6 months-19.24%
Current year-4.48%
1 week 0.24
Extreme 0.2435
0.27
1 month 0.24
Extreme 0.24
0.28
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.47
3 years 0.17
Extreme 0.1688
0.64
5 years 0.17
Extreme 0.1688
1.87
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 31/01/2024
Chief Operating Officer 62 30/11/2009
Chief Executive Officer 62 22/02/2018
Director TitleAgeSince
Director/Board Member 61 31/12/2019
Director/Board Member 50 13/05/2024
Director/Board Member - 13/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-3.03%-0.78%+5.57%-53.62% 32.85M
+0.35%-7.45%+11.26%-29.60% 16.47B
-0.23%-2.76%+28.35%+60.46% 1.67B
-0.65%-2.11%-31.56%+18.78% 1.11B
+0.28%-7.65%-54.38%-83.33% 961M
+2.05%-2.32%-23.41%-54.31% 635M
+1.38%-1.41%-46.80%-59.08% 561M
+0.09%+5.54%+26.61%-51.41% 465M
-1.57%-4.12%-55.54%-60.80% 391M
-2.34%-10.69%+44.34% - 337M
Average -0.37%+0.46%-9.56%-34.77% 2.26B
Weighted average by Cap. +0.24%-5.25%+4.86%-25.25%

Financials

2026 *2027 *
Net sales 19.1M 2.02M 1.75M 1.61M 1.51M 2.83M 192M 2.87M 7.41M 93.53M 7.6M 7.43M 327M 69.5M 7.36M 6.36M 5.86M 5.5M 10.3M 700M 10.45M 26.98M 340M 27.64M 27.05M 1.19B
Net income -28.9M -3.06M -2.64M -2.44M -2.29M -4.28M -291M -4.34M -11.22M -142M -11.49M -11.25M -494M 2.4M 254K 220K 202K 190K 356K 24.19M 361K 932K 11.75M 954K 934K 41.05M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
12/06/26 0.2560 kr -3.03% 1,246,142
11/06/26 0.2640 kr +1.93% 622,775
10/06/26 0.2590 kr +1.97% 2,144,047
09/06/26 0.2540 kr +0.99% 1,375,606
08/06/26 0.2515 kr -2.52% 1,338,016

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!